Literature DB >> 31278521

Culprit vessel-related myocardial mechanics and prognostic implications following acute myocardial infarction.

Sören J Backhaus1,2, Johannes T Kowallick2,3, Thomas Stiermaier4,5, Torben Lange1,2, Alexander Koschalka1,2, Jenny-Lou Navarra1,2, Joachim Lotz2,3, Shelby Kutty6, Boris Bigalke7, Matthias Gutberlet8, Hans-Josef Feistritzer9, Gerd Hasenfuß1,2, Holger Thiele9, Andreas Schuster10,11,12, Ingo Eitel4,5.   

Abstract

BACKGROUND: Prognosis in acute myocardial infarction (AMI) depends on the amount of infarct-related artery (IRA)-subtended myocardium and associated damage but has not been described in great detail. Consequently, we sought to describe IRA-associated pathophysiological consequences using cardiac magnetic resonance (CMR).
METHODS: 1235 AMI patients (n = 795 ST-elevation (STEMI) and 440 non-STEMI) underwent CMR following percutaneous coronary intervention. Blinded core-laboratory data were compared according to left anterior descending (LAD), left circumflex (LCx) and right coronary artery (RCA) regarding major adverse clinical events (MACE) within 12 months. Left ventricular (LV) global longitudinal/circumferential/radial (GLS/GCS/GRS) as well as left atrial (LA) total (εs), passive (εe) and active (εa) strains were determined using CMR-feature tracking. Tissue characterisation included infarct size (IS) and microvascular obstruction.
RESULTS: LAD and LCx were associated with higher mortality compared to RCA lesions (4.6% and 4.4% vs 1.6%). LAD lesions showed largest IS (16.8%), largest ventricular [LV ejection fraction (EF) 47.4%, GLS - 13.2%, GCS - 20.8%] and atrial (εs 20.2%) impairment. There was less impairment in LCx (IS 11.8%, LVEF 50.8%, GLS - 17.4%, GCS - 25.0%, εs 20.7%) followed by RCA lesions (IS 11.3%, LVEF 50.8%, GLS - 19.1%, GCS - 26.6%, εs 21.7%). In AUC analyses, εs (LAD, RCA) and GLS (LCx) best predicted MACE (AUC > 0.69). Multivariate analyses identified εs (p = 0.017) in LAD and GLS (p = 0.034) in LCx infarcts as independent predictors of MACE.
CONCLUSIONS: CMR allows IRA-specific phenotyping and characterisation of morphologic and functional changes. These alterations carry infarct-specific prognostic implications, and may represent novel diagnostic and therapeutic targets following AMI. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00712101 and NCT01612312.

Entities:  

Keywords:  Cardiac function; Cardiovascular magnetic resonance; Feature tracking; Infarct-related artery; Prognosis

Mesh:

Year:  2019        PMID: 31278521     DOI: 10.1007/s00392-019-01514-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  50 in total

1.  Left atrial volume: a powerful predictor of survival after acute myocardial infarction.

Authors:  Jacob E Moller; Graham S Hillis; Jae K Oh; James B Seward; Guy S Reeder; R Scott Wright; Seung W Park; Kent R Bailey; Patricia A Pellikka
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

2.  Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI.

Authors:  Kirian van der Weg; Wichert J Kuijt; Jan G P Tijssen; Sebastiaan C A M Bekkers; Joost D E Haeck; Cynthia L Green; Miguel E Lemmert; Robbert J de Winter; Anton P M Gorgels; Mitchell W Krucoff
Journal:  Int J Cardiol       Date:  2015-05-20       Impact factor: 4.164

3.  Correspondence between left ventricular 17 myocardial segments and coronary arteries.

Authors:  Osvaldo Pereztol-Valdés; Jaume Candell-Riera; César Santana-Boado; Juan Angel; Santiago Aguadé-Bruix; Joan Castell-Conesa; Ernest V Garcia; Jordi Soler-Soler
Journal:  Eur Heart J       Date:  2005-09-23       Impact factor: 29.983

4.  Optimized Prognosis Assessment in ST-Segment-Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score.

Authors:  Thomas Stiermaier; Alexander Jobs; Suzanne de Waha; Georg Fuernau; Janine Pöss; Steffen Desch; Holger Thiele; Ingo Eitel
Journal:  Circ Cardiovasc Imaging       Date:  2017-11       Impact factor: 7.792

5.  Atrial Infarction and Ischemic Mitral Regurgitation Contribute to Post-MI Remodeling of the Left Atrium.

Authors:  Jaume Aguero; Carlos Galan-Arriola; Rodrigo Fernandez-Jimenez; Javier Sanchez-Gonzalez; Nina Ajmone; Victoria Delgado; Jorge Solis; Gonzalo J Lopez; Antonio de Molina-Iracheta; Roger J Hajjar; Jeroen J Bax; Valentin Fuster; Borja Ibáñez
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

6.  Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging.

Authors:  José T Ortiz-Pérez; José Rodríguez; Sheridan N Meyers; Daniel C Lee; Charles Davidson; Edwin Wu
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

7.  Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.

Authors:  Georg Fuernau; Karl Fengler; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Christian Jung; Michael Böhm; Janine Pöss; Ruth H Strasser; Steffen Schneider; Taoufik Ouarrak; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2016-07-04       Impact factor: 5.460

8.  Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study.

Authors:  Johannes Tammo Kowallick; Shelby Kutty; Frank Edelmann; Amedeo Chiribiri; Adriana Villa; Michael Steinmetz; Jan Martin Sohns; Wieland Staab; Nuno Bettencourt; Christina Unterberg-Buchwald; Gerd Hasenfuß; Joachim Lotz; Andreas Schuster
Journal:  J Cardiovasc Magn Reson       Date:  2014-08-12       Impact factor: 5.364

9.  Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

Authors:  Rajendra H Mehta; Aijing Z Starr; Renato D Lopes; Judith S Hochman; Petr Widimsky; Karen S Pieper; Paul W Armstrong; Christopher B Granger
Journal:  JAMA       Date:  2009-05-06       Impact factor: 56.272

10.  Cardiovascular magnetic resonance feature-tracking assessment of myocardial mechanics: Intervendor agreement and considerations regarding reproducibility.

Authors:  A Schuster; V-C Stahnke; C Unterberg-Buchwald; J T Kowallick; P Lamata; M Steinmetz; S Kutty; M Fasshauer; W Staab; J M Sohns; B Bigalke; C Ritter; G Hasenfuß; P Beerbaum; J Lotz
Journal:  Clin Radiol       Date:  2015-06-29       Impact factor: 2.350

View more
  8 in total

1.  Global longitudinal strain by feature tracking for optimized prediction of adverse remodeling after ST-elevation myocardial infarction.

Authors:  Martin Reindl; Christina Tiller; Magdalena Holzknecht; Ivan Lechner; Dorothea Eisner; Laura Riepl; Mathias Pamminger; Benjamin Henninger; Agnes Mayr; Johannes P Schwaiger; Gert Klug; Axel Bauer; Bernhard Metzler; Sebastian J Reinstadler
Journal:  Clin Res Cardiol       Date:  2020-04-15       Impact factor: 5.460

2.  Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.

Authors:  Andreas Seitz; Kai C Wollert; Gerd P Meyer; Jochen Müller-Ehmsen; Carsten Tschöpe; Andreas E May; Klaus Empen; Emmanuel Chorianopoulos; Benedikta Ritter; Jens Pirr; Lubomir Arseniev; Hans-Gert Heuft; Arnold Ganser; Eed Abu-Zaid; Hugo A Katus; Stephan B Felix; Meinrad P Gawaz; Heinz-Peter Schultheiss; Dennis Ladage; Johann Bauersachs; Heiko Mahrholdt; Simon Greulich
Journal:  Clin Res Cardiol       Date:  2019-08-10       Impact factor: 5.460

3.  Myocardial salvage is increased after sympathetic renal denervation in a pig model of acute infarction.

Authors:  Luigi Emilio Pastormerlo; Silvia Burchielli; Marco Ciardetti; Giovanni Donato Aquaro; Chrysantos Grigoratos; Vincenzo Castiglione; Angela Pucci; Maria Franzini; Assuero Giorgetti; Paolo Marzullo; Eleonora Benelli; Silvia Masotti; Veronica Musetti; Fabio Bernini; Sergio Berti; Claudio Passino; Michele Emdin
Journal:  Clin Res Cardiol       Date:  2020-06-08       Impact factor: 5.460

4.  Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient.

Authors:  Martin Hinterseer; Martin Zens; Roland Jean Wimmer; Simon Delladio; Susanne Lederle; Christian Kupatt; Bernd Hartmann
Journal:  Clin Res Cardiol       Date:  2020-05-19       Impact factor: 5.460

Review 5.  Quantification of Myocardial Deformation Applying CMR-Feature-Tracking-All About the Left Ventricle?

Authors:  Torben Lange; Andreas Schuster
Journal:  Curr Heart Fail Rep       Date:  2021-05-01

6.  Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors-A DANAMI-3 substudy.

Authors:  Jawad Mazhar; Kathrine Ekström; Rebecca Kozor; Stuart M Grieve; Lars Nepper-Christensen; Kiril A Ahtarovski; Henning Kelbæk; Dan E Høfsten; Lars Køber; Niels Vejlstrup; Stephen T Vernon; Thomas Engstrøm; Jacob Lønborg; Gemma A Figtree
Journal:  Front Cardiovasc Med       Date:  2022-08-03

7.  Impact of Right Atrial Physiology on Heart Failure and Adverse Events after Myocardial Infarction.

Authors:  Andreas Schuster; Sören J Backhaus; Thomas Stiermaier; Jenny-Lou Navarra; Johannes Uhlig; Karl-Philipp Rommel; Alexander Koschalka; Johannes T Kowallick; Boris Bigalke; Shelby Kutty; Matthias Gutberlet; Gerd Hasenfuß; Holger Thiele; Ingo Eitel
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

8.  Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters.

Authors:  Magdalena Holzknecht; Martin Reindl; Christina Tiller; Sebastian J Reinstadler; Ivan Lechner; Mathias Pamminger; Johannes P Schwaiger; Gert Klug; Axel Bauer; Bernhard Metzler; Agnes Mayr
Journal:  Clin Res Cardiol       Date:  2021-04-21       Impact factor: 5.460

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.